Latest On Tekla Life Sciences Investors (HQL):
About Tekla Life Sciences Investors (HQL):
Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. It was formerly known as H&Q Life Sciences Investors fund. Tekla Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.
General
- Name Tekla Life Sciences Investors
- Symbol HQL
- Type Common Stock
- Exchange NYSE
- Currency USD
- Country USA
- SectorFinancial Services
- IndustryAsset Management
- Fiscal Year EndSeptember
- IPO Date1992-05-04
- Web URLhttp://www.teklacap.com/hql.html
Valuation
- Trailing PE 3.92
- Price/Sales (Trailing 12 Mt.) 3.99
- Price/Book (Most Recent Quarter) 1.02
Financials
- Most Recent Quarter 2020-09-30
- Profit Margin 3628%
- Operating Margin -62%
- Return on Equity 28%
- Revenue 3.39 million
- Earnings Per Share $5.15
- Revenue Per Share $0.14
- Gross Profit 3.39 million
- Quarterly Earnings Growth -7.8%
ESG Rating
Highlights
- Market Capitalization 482.2 million
- Book Value Per Share $20.25
Share Statistics
- Shares Outstanding 23.88 million
- % Held by Insiders <1%
- % Held by Institutions 20.21%
- Shares Short 115655
- Shares Short Prior Month 8497
- Short Ratio 1.42
Technicals
- Beta 0.98
- 52 Week High $21.88
- 52 Week Low $11.14
- 50 Day Moving Average 20.93
- 200 Day Moving Average 19.14
Dividends
- Forward Annual Dividend Rate $1.72
- Forward Annual Dividend Yield 8.34%
- Payout Ratio 32%
- Dividend Date 2018-12-31
- ExDividend Date 2021-02-25
- Dividend Per Share $1.47
- Dividend Yield 9.39%
Tekla Life Sciences Investors (HQL) Dividend Calendar:
Tekla Life Sciences Investors pays an annual dividend of $1.72 per share, with a dividend yield of 9.39%.
HQL's last dividend payment was made to shareholders on December 31, 2018.
Tekla Life Sciences Investors pays out 32% of its earnings out as a dividend.
Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
---|
Tekla Life Sciences Investors (HQL) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
---|---|---|---|---|---|
2020-06-30 | 2020-09-30 | $N/A | $1.94 | $0.00 | |
2020-03-31 | 2020-06-30 | $N/A | $1.94 | $0.00 | |
2019-12-31 | 2020-03-31 | $N/A | $0.64 | $0.00 | |
2019-09-30 | 2019-12-31 | $657010 | $0.64 | $0.00 | |
2019-06-30 | 2019-09-30 | $657010 | -$0.68 | $0.00 | |
2019-03-31 | 2019-06-30 | $563283 | -$0.68 | $0.00 | |
2018-12-31 | 2019-03-31 | $563283 | -$0.86 | $0.00 | |
2018-09-30 | 2018-12-31 | $494381 | -$0.86 | $0.00 | |
2018-06-30 | 2018-09-30 | $494381 | $1.08 | $0.00 | |
2018-03-31 | 2018-06-30 | $498531 | $1.08 | $0.00 | |
2017-12-31 | 2018-03-31 | $498531 | -$0.45 | $0.00 | |
2017-09-30 | 2017-12-31 | $1.24 million | -$0.45 | $0.00 | |
2017-06-30 | 2017-09-30 | $445744 | $0.97 | $0.00 | |
2017-03-31 | 2017-06-30 | $N/A | $0.97 | $0.00 | |
2016-12-31 | 2017-03-31 | $N/A | $0.63 | $0.00 | |
2016-09-30 | 2016-12-31 | $1.44 million | $0.63 | $0.00 | |
2016-06-30 | 2016-09-30 | $N/A | $1.38 | $0.00 | |
2016-03-31 | 2016-06-30 | $N/A | $1.38 | $0.00 | |
2015-12-31 | 2016-03-31 | $N/A | -$1.72 | $0.00 | |
2015-09-30 | 2015-12-31 | $1.32 million | -$1.72 | $0.00 | |
2015-06-30 | 2015-09-30 | $N/A | -$1.28 | $0.00 | |
2015-03-31 | 2015-06-30 | $N/A | -$1.28 | $0.00 | |
2014-12-31 | 2015-03-31 | $N/A | $2.36 | $0.00 | |
2014-09-30 | 2014-12-31 | $876788 | $2.36 | $0.00 | |
2014-06-30 | 2014-09-30 | $N/A | $1.41 | $0.00 | |
2014-03-31 | 2014-06-30 | $N/A | $1.41 | $0.00 | |
2013-12-31 | 2014-03-31 | $N/A | $1.16 | $0.00 | |
2013-09-30 | 2013-12-31 | $N/A | $1.16 | $0.00 | |
2013-06-30 | 2013-09-30 | $N/A | $1.96 | $0.00 | |
2013-03-31 | 2013-06-30 | $N/A | $1.96 | $0.00 | |
2012-12-31 | 2013-03-31 | $N/A | $0.88 | $0.00 | |
2012-09-30 | 2012-12-31 | $N/A | $0.88 | $0.00 | |
2012-06-30 | 2012-09-30 | $N/A | $0.80 | $0.00 | |
2012-03-31 | 2012-06-30 | $N/A | $0.80 | $0.00 | |
2011-12-31 | 2012-03-31 | $N/A | $1.92 | $0.00 | |
2011-09-30 | 2011-12-31 | $N/A | $1.92 | $0.00 | |
2011-06-30 | 2011-09-30 | $N/A | -$0.19 | $0.00 | |
2011-03-31 | 2011-06-30 | $N/A | -$0.19 | $0.00 | |
2010-12-31 | 2011-03-31 | $N/A | $0.97 | $0.00 | |
2010-09-30 | 2010-12-31 | $N/A | $0.97 | $0.00 |
Tekla Life Sciences Investors (HQL) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
Date |
---|
Research Development |
Income Before Tax |
Selling General Administrative |
Gross Profit |
Ebit |
Operating Income |
Income Tax Expense |
Total Revenue |
Cost of Revenue |
Total Other Income Expense Net |
Net Income From Continuing Operations |
Net Income Applicable to Common Shares |
Cash Flow:
Date |
---|
Investments |
Change to Liabilities |
Total Cash Flow from Investing Activities |
Net Borrowings |
Total Cash Flow from Financial Activities |
Change to Operating Activities |
Change in Cash |
Total Cash from Operating Activities |
Depreciation |
Other Cash Flow from Investing Activities |
Change to Inventory |
Change to Account Receivables |
Other Cash Flow from Financing Activities |
Change to Net Income |
Capital Expenditures |
Balance Sheet:
Date |
---|
Total Liabailities |
Total Stockholder Equity |
Other Current Liabilities |
Total Assets |
Common Stock |
Other Current Assets |
Retained Earnings |
Other Liabilities |
Other Assets |
Cash |
Total Current Liabilities |
Other Stockholder Equity |
Property, Plant & Equipment |
Total Current Assets |
Long Term Investments |
Net Tangible Assets |
Short Term Investments |
Long Term Debt |
Inventory |
Accounts Payable |
Tekla Life Sciences Investors (HQL) Chart:
Tekla Life Sciences Investors (HQL) News:
Below you will find a list of latest news for Tekla Life Sciences Investors (HQL) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Tekla Life Sciences Investors (HQL) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
---|
Latest HQL Trades:
Date | Shares | Price |
---|---|---|
Jun 13, 2022 4:16 PM EST | 100 | $13.19 |
Jun 13, 2022 5:29 PM EST | 100 | $13.23 |
Jun 13, 2022 5:29 PM EST | 100 | $13.23 |
Jun 13, 2022 6:07 PM EST | 100 | $13.29 |
Jun 13, 2022 6:07 PM EST | 100 | $13.27 |
Tekla Life Sciences Investors (HQL) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
Date | Form Type | Form Name | Link |
---|---|---|---|
2017-06-19 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/884121/000110465917040117/0001104659-17-040117-index.htm |
2017-06-19 | POS EX | Post-effective amendment adding exhibits to registration statement [Rule 462(d)] | https://www.sec.gov/Archives/edgar/data/884121/000110465917040137/0001104659-17-040137-index.htm |
2017-07-18 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/884121/000110465917045485/0001104659-17-045485-index.htm |
2017-07-27 | 40-17G | Fidelity Bond [Rule 17G-1(g)] | https://www.sec.gov/Archives/edgar/data/884121/000110465917047330/0001104659-17-047330-index.htm |
2017-08-25 | N-Q | Quarterly Schedule of portfolio holdings of management investment companies | https://www.sec.gov/Archives/edgar/data/884121/000110465917053653/0001104659-17-053653-index.htm |
2017-08-30 | N-PX | Annual Report of proxy voting record of management investment companies | https://www.sec.gov/Archives/edgar/data/884121/000110465917054431/0001104659-17-054431-index.htm |
2017-12-05 | N-CSR | Certified Shareholder Report | https://www.sec.gov/Archives/edgar/data/884121/000110465917071866/0001104659-17-071866-index.htm |
2018-02-23 | N-Q | Quarterly Schedule of portfolio holdings of management investment companies | https://www.sec.gov/Archives/edgar/data/884121/000110465918011670/0001104659-18-011670-index.htm |
2018-04-18 | POS EX | Post-effective amendment adding exhibits to registration statement [Rule 462(d)] | https://www.sec.gov/Archives/edgar/data/884121/000110465918024689/0001104659-18-024689-index.htm |
2018-04-18 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/884121/000110465918024806/0001104659-18-024806-index.htm |
2018-04-25 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/884121/000110465918026537/0001104659-18-026537-index.htm |
2018-06-01 | N-CSRS | Certified Shareholder Report, Semi-Annual | https://www.sec.gov/Archives/edgar/data/884121/000110465918037523/0001104659-18-037523-index.htm |
2018-07-27 | 40-17G | Fidelity Bond [Rule 17G-1(g)] | https://www.sec.gov/Archives/edgar/data/884121/000110465918047582/0001104659-18-047582-index.htm |
2018-08-20 | N-PX | Annual Report of proxy voting record of management investment companies | https://www.sec.gov/Archives/edgar/data/884121/000110465918052797/0001104659-18-052797-index.htm |
2018-08-28 | N-Q | Quarterly Schedule of portfolio holdings of management investment companies | https://www.sec.gov/Archives/edgar/data/884121/000110465918053894/0001104659-18-053894-index.htm |
2018-12-04 | N-CSR | Certified Shareholder Report | https://www.sec.gov/Archives/edgar/data/884121/000110465918071295/0001104659-18-071295-index.htm |
2018-12-19 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/884121/000110465918073771/0001104659-18-073771-index.htm |
2019-02-26 | N-Q | Quarterly Schedule of portfolio holdings of management investment companies | https://www.sec.gov/Archives/edgar/data/884121/000110465919010644/0001104659-19-010644-index.htm |
2019-03-12 | POS EX | Post-effective amendment adding exhibits to registration statement [Rule 462(d)] | https://www.sec.gov/Archives/edgar/data/884121/000110465919014168/0001104659-19-014168-index.htm |
2019-04-15 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/884121/000110465919021281/0001104659-19-021281-index.htm |
2019-04-15 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/884121/000110465919021314/0001104659-19-021314-index.htm |
2019-06-05 | N-CSRS | Certified Shareholder Report, Semi-Annual | https://www.sec.gov/Archives/edgar/data/884121/000110465919033995/0001104659-19-033995-index.htm |
2019-06-20 | POS EX | Post-effective amendment adding exhibits to registration statement [Rule 462(d)] | https://www.sec.gov/Archives/edgar/data/884121/000110465919036644/0001104659-19-036644-index.htm |
2019-08-15 | 40-17G | Fidelity Bond [Rule 17G-1(g)] | https://www.sec.gov/Archives/edgar/data/884121/000110465919046051/0001104659-19-046051-index.htm |
2019-08-15 | N-PX | Annual Report of proxy voting record of management investment companies | https://www.sec.gov/Archives/edgar/data/884121/000110465919046053/0001104659-19-046053-index.htm |
2019-12-05 | N-CSR | Certified Shareholder Report | https://www.sec.gov/Archives/edgar/data/884121/000110465919070186/0001104659-19-070186-index.htm |
2020-03-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/884121/000110465920034866/0001104659-20-034866-index.htm |
2020-04-14 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/884121/000110465920046205/0001104659-20-046205-index.htm |
2020-05-08 | CORRESP | Correspondence | https://www.sec.gov/Archives/edgar/data/884121/000110465920058473/0001104659-20-058473-index.htm |
2020-05-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/884121/000110465920065199/0001104659-20-065199-index.htm |
2020-06-05 | N-CSRS | Certified Shareholder Report, Semi-Annual | https://www.sec.gov/Archives/edgar/data/884121/000110465920070287/0001104659-20-070287-index.htm |
2020-08-06 | 40-17G | Fidelity Bond [Rule 17G-1(g)] | https://www.sec.gov/Archives/edgar/data/884121/000110465920091251/0001104659-20-091251-index.htm |
2020-08-17 | N-PX | Annual Report of proxy voting record of management investment companies | https://www.sec.gov/Archives/edgar/data/884121/000110465920095898/0001104659-20-095898-index.htm |
2020-08-28 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/884121/000110465920100107/0001104659-20-100107-index.htm |
2020-09-10 | POS EX | Post-effective amendment adding exhibits to registration statement [Rule 462(d)] | https://www.sec.gov/Archives/edgar/data/884121/000110465920103794/0001104659-20-103794-index.htm |
2020-09-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/884121/000110465920107789/0001104659-20-107789-index.htm |
2020-10-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/884121/000110465920116861/0001104659-20-116861-index.htm |
2020-10-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/884121/000110465920118221/0001104659-20-118221-index.htm |
2017-11-27 | NSAR-B | Annual report for management companies | https://www.sec.gov/Archives/edgar/data/884121/000141036817001710/0001410368-17-001710-index.htm |
2018-05-25 | NSAR-A | Semi-annual report for management companies | https://www.sec.gov/Archives/edgar/data/884121/000141036818000796/0001410368-18-000796-index.htm |
2019-01-28 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/884121/000144554619000483/0001445546-19-000483-index.htm |
2019-07-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/884121/000144554619002968/0001445546-19-002968-index.htm |
2020-02-03 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/884121/000144554620000619/0001445546-20-000619-index.htm |
2018-01-18 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/884121/000172856418000002/0001728564-18-000002-index.htm |
2018-01-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/884121/000172856418000006/0001728564-18-000006-index.htm |
2018-12-13 | N-CEN | Annual Report for Registered Investment Companies | https://www.sec.gov/Archives/edgar/data/884121/000175272418002635/0001752724-18-002635-index.htm |
2019-08-29 | NPORT-EX | Portfolio Holdings Exhibit to Form N-PORT | https://www.sec.gov/Archives/edgar/data/884121/000175272419115617/0001752724-19-115617-index.htm |
2019-11-15 | NPORT-P | Monthly Portfolio Investments Report on Form N-PORT (Public) | https://www.sec.gov/Archives/edgar/data/884121/000175272419163927/0001752724-19-163927-index.htm |
2019-12-12 | N-CEN | Annual Report for Registered Investment Companies | https://www.sec.gov/Archives/edgar/data/884121/000175272419188841/0001752724-19-188841-index.htm |
2020-02-27 | NPORT-P | Monthly Portfolio Investments Report on Form N-PORT (Public) | https://www.sec.gov/Archives/edgar/data/884121/000175272420040416/0001752724-20-040416-index.htm |
2020-05-28 | NPORT-P | Monthly Portfolio Investments Report on Form N-PORT (Public) | https://www.sec.gov/Archives/edgar/data/884121/000175272420108408/0001752724-20-108408-index.htm |
2020-08-25 | NPORT-P | Monthly Portfolio Investments Report on Form N-PORT (Public) | https://www.sec.gov/Archives/edgar/data/884121/000175272420169816/0001752724-20-169816-index.htm |
Tekla Life Sciences Investors (HQL) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Tekla Life Sciences Investors (HQL). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: < 1%Institutional Ownership: 2021%
Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
---|---|---|---|---|---|---|---|---|
2020-03-17 | DANIEL R OMSTEAD | President | Buy | 8,300.00 | 13.27 | 110,106.97 | 105,813.88 | https://www.sec.gov/Archives/edgar/data/884121/000110465920034866/0001104659-20-034866-index.htm |
2020-05-21 | DANIEL R OMSTEAD | President | Buy | 5,950.00 | 17.74 | 105,556.57 | 114,820.99 | https://www.sec.gov/Archives/edgar/data/884121/000110465920065199/0001104659-20-065199-index.htm |
2020-10-21 | DANIEL R OMSTEAD | President | Buy | 5,950.00 | 17.75 | 105,605.96 | 125,660.80 | https://www.sec.gov/Archives/edgar/data/884121/000110465920116861/0001104659-20-116861-index.htm |
2018-01-25 | Thomas M Kent | Director | Buy | 1,300.00 | 21.04 | 27,347.97 | 1,300.00 | https://www.sec.gov/Archives/edgar/data/884121/000172856418000006/0001728564-18-000006-index.htm |
2020-10-26 | DANIEL R OMSTEAD | President | Buy | 6,175.00 | 17.52 | 108,203.91 | 131,835.80 | https://www.sec.gov/Archives/edgar/data/884121/000110465920118221/0001104659-20-118221-index.htm |
2020-09-22 | Jeffrey Allen Bailey | Director | Buy | 580.00 | 17.28 | 10,022.40 | 580.00 | https://www.sec.gov/Archives/edgar/data/884121/000110465920107789/0001104659-20-107789-index.htm |